NCT02197403

Brief Summary

  1. 1.Adequate sedation with classical sedative agents, propofol
  2. 2.Sedation with propofol may induce paradoxical excitement response in heavy alcohol drinkers
  3. 3.Dexmedetomidine, α2 receptor agonist, may provide adequate sedation in heavy alcohol drinkers

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
110

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Dec 2013

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 22, 2014

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2019

Completed
Last Updated

March 14, 2019

Status Verified

March 1, 2019

Enrollment Period

5.5 years

First QC Date

July 21, 2014

Last Update Submit

March 12, 2019

Conditions

Keywords

DexmedetomidineSedationParadoxical excitement responseAlcohol drinkers

Outcome Measures

Primary Outcomes (1)

  • Paradoxical excitement response

    Paradoxical excitement responses (verbal/movement) 0, none : no excitement response 1. mild : increased talkativeness, irrational talking / brief spontaneous movement with position remaining 2. moderate : restlessness, loss of cooperation, spontaneous movements requiring repositioning with no need of restraint 3. severe : agitation and spontaneous movements with a need to restrain the patient

    Every 5 minutes up to 120minutes after drug infusion

Secondary Outcomes (2)

  • OAA/S

    Every 5minutes up to 120minutes after drug infusion

  • Vital signs

    During operation

Study Arms (4)

alcohol drinker & dexmedetomidine

EXPERIMENTAL

dexmedetomidine, 200mcg in 50mL of normal saline 0.75mcg/Kg bolus injection in 10 minutes 0.1\~1.0mcg/Kg infusion during surgery

Drug: Dexmedetomidine

alcohol drinker & propofol

ACTIVE COMPARATOR

Propofol (2% fresofol) 25\~75mcg/kg/min continuous infusion

Drug: Propofol

Non-alcohol drinker & dexmedetomidine

ACTIVE COMPARATOR

dexmedetomidine, 200mcg in 50mL of normal saline 0.75mcg/Kg bolus injection in 10 minutes 0.1\~1.0mcg/Kg infusion during surgery

Drug: Dexmedetomidine

Non-alcohol drinker & propofol

ACTIVE COMPARATOR

Propofol (2% fresofol) 25\~75mcg/kg/min continuous infusion

Drug: Propofol

Interventions

200mcg in 50mL of normal saline 0.75mcg/Kg bolus injection in 10 minutes 0.1\~1.0mcg/Kg infusion

Also known as: Precedex
Non-alcohol drinker & dexmedetomidinealcohol drinker & dexmedetomidine

25\~75mcg/kg/min continuous infusion

Also known as: Fresofol
Non-alcohol drinker & propofolalcohol drinker & propofol

Eligibility Criteria

Age19 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \~65 yr-old patients who is scheduled to undergo knee surgery with regional anesthesia

You may not qualify if:

  • History of taking anxiolytics, hypnotics, antiepileptic drugs
  • Abnormal liver function test (eg: Liver cirrhosis, elevated liver enzymes)
  • History of allergic reaction with dexmedetomidine or propofol
  • Contraindication with regional anesthesia
  • American society of anesthesiologist Physical status III or IV

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chonnam National University Hwasun Hospital

Hwasun, Jeollanamdo, 501-757, South Korea

RECRUITING

Related Publications (4)

  • Jeong S, Lee HG, Kim WM, Jeong CW, Lee SH, Yoon MH, Choi JI. Increase of paradoxical excitement response during propofol-induced sedation in hazardous and harmful alcohol drinkers. Br J Anaesth. 2011 Dec;107(6):930-3. doi: 10.1093/bja/aer275. Epub 2011 Sep 7.

  • Adams R, Brown GT, Davidson M, Fisher E, Mathisen J, Thomson G, Webster NR. Efficacy of dexmedetomidine compared with midazolam for sedation in adult intensive care patients: a systematic review. Br J Anaesth. 2013 Nov;111(5):703-10. doi: 10.1093/bja/aet194. Epub 2013 Jun 7.

  • Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, Bratty JR, Takala J; Dexmedetomidine for Long-Term Sedation Investigators. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012 Mar 21;307(11):1151-60. doi: 10.1001/jama.2012.304.

  • Candiotti KA, Bergese SD, Bokesch PM, Feldman MA, Wisemandle W, Bekker AY; MAC Study Group. Monitored anesthesia care with dexmedetomidine: a prospective, randomized, double-blind, multicenter trial. Anesth Analg. 2010 Jan 1;110(1):47-56. doi: 10.1213/ane.0b013e3181ae0856. Epub 2009 Aug 27.

MeSH Terms

Conditions

Alcohol Drinking

Interventions

DexmedetomidinePropofol

Condition Hierarchy (Ancestors)

Drinking BehaviorBehavior

Intervention Hierarchy (Ancestors)

ImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Hyunjung Lee, MD, Master

    Chonnam National University Hospital

    PRINCIPAL INVESTIGATOR
  • Jeongil Choi, MD, PhD

    Chonnam National University Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 21, 2014

First Posted

July 22, 2014

Study Start

December 1, 2013

Primary Completion

May 31, 2019

Study Completion

May 31, 2019

Last Updated

March 14, 2019

Record last verified: 2019-03

Locations